SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Welcome to the POTP board, the DPP-IV company -- Ignore unavailable to you. Want to Upgrade?

To: rareearth42 who wrote (43)11/18/2006 9:10:03 AM
From: rkrw  Read Replies (2) | Respond to of 90
 
OT MCU. Thanks!

On the other hand, did you see what abt paid for kosp (niacin) and what amag (iron) is selling for? Maybe it's the coming of vitamins and minerals. :-)

I hear what you're saying though, how can they get pricing when iv formulations already exist? I suppose they'll hang their hat on a patent, indicated use, threats and see what they can get away with?



To: rareearth42 who wrote (43)11/19/2006 10:04:03 AM
From: drbio45  Read Replies (1) | Respond to of 90
 
Mc1 is an analogue of B-6 it is not the vitamin.

In fact vitamin B-6 would cause inflamation in this indication and make the prognosis of the patient worse so the it would not be used in place of mc-1


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News